Elzonris (Page 5 of 5)

PRINCIPAL DISPLAY PANEL — NDC: 72187-0401-1 — 1000 mcg/mL Vial Label

1000 mcgg/mL Vial Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — NDC: 72187-0401-1 — 1000 mcg/mL Carton Label

1000 mcgg/mL Carton Label
(click image for full-size original)

ELZONRIS tagraxofusp injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72187-0401
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TAGRAXOFUSP (TAGRAXOFUSP) TAGRAXOFUSP 1000 ug in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE 4.38 mg in 1 mL
SORBITOL 50 mg in 1 mL
TROMETHAMINE 2.42 mg in 1 mL
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72187-0401-1 1 VIAL, SINGLE-DOSE in 1 CARTON contains a VIAL, SINGLE-DOSE
1 1 mL in 1 VIAL, SINGLE-DOSE This package is contained within the CARTON (72187-0401-1)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA761116 01/18/2019
Labeler — Stemline Therapeutics, Inc. (139606136)
Establishment
Name Address ID/FEI Operations
Alcami Carolinas Corporation 832394733 MANUFACTURE (72187-0401)

Revised: 11/2022 Stemline Therapeutics, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

https://medlibrary.org/lib/rx/meds/elzonris/page/5/

Clinical Trials

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.